NFKBIA and neoplasm: This promotes the degradation of IκBα by the μ-calpain protease, thereby allowing nuclear factor kappa B (NF-κB) to be released from IκBα binding and translocated into the nucleus, enhancing Programmed death-ligand 1(PD-L1) transcription and promoting tumor immune escape 23.